Mark Hershowitz, O.D.
Optometrist in Watertown, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 61,426 in Optometrist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Mark Hershowitz, O.D. reported a CMS MIPS final score of 62.6/100 - below the 83.5 national average - and filed 2,743 Medicare Part D claims in 2024.
- 62.6/100
- MIPS score · -21 vs avg
- 3K
- Part D claims, 2024
- 48%
- generic prescribing
- $470.56
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Mark Hershowitz, O.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1275530834), first enumerated 06/28/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 2,743 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 62.6/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$470.56 in reported industry payments (24 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
New York statewide board action statistics are published annually — these figures describe aggregate state activity, not Mark Hershowitz, O.D.'s individual license status. Verify directly with the state medical board.
Source: NYSBPMC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1275530834 · Optometrist
NPI-10 · ENUM-LEGACY · TAX-MEGA · MIPS-LOW · RX-MID · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1275530834
- ENUM-LEGACY 2005
- TAX-MEGA 61K Optometrist
- MIPS-LOW 62.6/100
- RX-MID 2,743
- BOOK-LIGHT 3,490 in New York
- PHOTO-FINISH Chad Belanger, OD · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Hershowitz · thi…
Hershowitz · this provider
62.6 MIPS pts
- Chad Belanger, O…
Chad Belanger, OD
62.6 MIPS pts
- Erin Miller · hi…
Erin Miller
62.8 MIPS pts
- Luke Lirones · n…
Luke Lirones
62.8 MIPS pts
- Andrea Lirones, …
Andrea Lirones, OD
62.8 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Mark Hershowitz, O.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
63 ≥ 6th percentile 6% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Mark Hershowitz, O.D. sits
This provider among optometrist peers
Across the 6,187 optometrist providers who report both Medicare Part D prescribing and a MIPS quality score, Mark Hershowitz, O.D. writes more Part D claims than 98% of them and scores higher on MIPS quality than 14% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one optometrist peer from a representative sample of 60; the gold marker is Mark Hershowitz, O.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Mark Hershowitz, O.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New York
How Optometrist compares to other specialties among New York providers
Optometrist ranks #35 among New York's specialties (0.6% of in-state providers)
Each bar is a specialty's share of the New York provider total, by primary NUCC taxonomy. The highlighted bar is Optometrist; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Mark Hershowitz, O.D.'s 2023 MIPS final score plotted against the Optometrist national average
- MIPS Final Score
- 62.6/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Optometrist US NPIs
62.6/100 MIPS final score - 20.9 pts below the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Optometrist. Quality dim: 59.7. Cost dim: 29.2.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1275530834 |
|---|---|
| Specialty | Optometrist |
| Credentials | O.D. |
| Gender | Male |
| NPI Issued | 06/28/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Mark Hershowitz, O.D.'s current license status, disciplinary history, and board certifications with the New York State Education Department, Office of the Professions in New York before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1275530834 is the unique 10-digit identifier CMS uses to link Hershowitz across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Mark Hershowitz, O.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mark Hershowitz, O.D.. Source: openpaymentsdata.cms.gov.
Total received
$471
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Mark Hershowitz, O.D.. To verify Mark Hershowitz, O.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
52% brand-name claims vs 48% generic, on 2,743 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 6,642.2
- Total Day Supply
- 197,501
- Brand vs Generic
- 52% brand / 48% generic
- Brand Drug Cost
- $662K
- Generic Drug Cost
- $95K
Patient Demographics
- Average Patient Age
- 76.8 years
- Avg HCC Risk Score
- 1.08
- Gender Split
- 61% female / 39% male
- Age Distribution
- <65: 29, 65-74: 268, 75-84: 254, 85+: 143
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Mark Hershowitz, O.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Latanoprost
Latanoprost
842 claims
- Dorzolamide-Timolol 279
Dorzolamide-Timolol
279 claims
- Lumigan 269
Lumigan
269 claims
- Timolol Maleate 232
Timolol Maleate
232 claims
- Brimonidine Tartrate 143
Brimonidine Tartrate
143 claims
- Dorzolamide Hcl 103
Dorzolamide Hcl
103 claims
- Cyclosporine 88
Cyclosporine
88 claims
- Travoprost 81
Travoprost
81 claims
| Drug | Claims |
|---|---|
| Latanoprost | 842 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 279 |
| Lumigan Bimatoprost | 269 |
| Timolol Maleate | 232 |
| Brimonidine Tartrate | 143 |
| Dorzolamide Hcl | 103 |
| Cyclosporine | 88 |
| Travoprost | 81 |
| Restasis Cyclosporine | 76 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 68 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Optometrist Overview
How Mark Hershowitz, O.D. fits within the Optometrist landscape nationally.
Mark Hershowitz, O.D.'s 2,743 claims are above the specialty average of 279.
Nationwide Optometrist peers with similar MIPS or enrollment year
Two federal-record peer sets for Hershowitz, both outside New York so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (62.6 here).
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Optometrist Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Hershowitz.
One of 3,490 Optometrist providers enrolled in New York, 5 are shown here.
Compare Optometrist nationally: see state-by-state distribution →
Frequently Asked Questions
What is Mark Hershowitz, O.D.'s specialty? ▼
How much does Mark Hershowitz, O.D. prescribe under Medicare Part D? ▼
What is Mark Hershowitz, O.D.'s Medicare quality score? ▼
Where is Mark Hershowitz, O.D. located? ▼
What is Mark Hershowitz, O.D.'s NPI number? ▼
Does Mark Hershowitz, O.D. prescribe more brand-name or generic drugs? ▼
How many Optometrist providers are there in the US? ▼
What drugs does Mark Hershowitz, O.D. prescribe most often? ▼
Does Mark Hershowitz, O.D. accept Medicare? ▼
How can I verify Mark Hershowitz, O.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.